You showed us the critical importance of scaling Calibrate. You gave us feedback to design a more effective program. You worked with us to build the right team. You appreciated how the size of the market compels urgency - the largest category of chronic disease, 5x bigger than diabetes, with 175 million Americans to treat. You believed in Calibrate when it was an idea, a deck, a landing page, a single Google review (from my mom), and today your commitment to scaling access to Calibrate demonstrates how the power of our outcomes cemented your support.
You made the ultimate bet on me as a leader. We have learned so much, so quickly, and I am so excited to show some of “the how” that made this happen.īut first I have to share how endlessly grateful I am to our team of Calibraters, our investors, our Clinical Advisors, our Expert Council, and our trailblazing Early Access members. Along the way, I interviewed every single Calibrater we hired and spoke to hundreds of the members who joined our Early Access program. To support this growth, we’ve expanded our team from 10 in June 2020 to 170 team members today. Since we launched, we’ve grown our business 51% month-over-month and have had the fastest state expansion on record for a telemedicine startup - Calibrate is already live for more than 80% of the US population. So far, 75% of our members who have finished their One-Year Metabolic Reset have joined a Year 2 Calibrate Masters program, allowing us to ensure their long-term success and build out the longitudinal data platform to establish the standard of care for obesity treatment.
Their wins also go far beyond the scale, and they report improvements in how they eat, sleep, exercise, and manage their emotional health. Calibrate works, and our members’ successes tell the story. Our first cohort of members lost an averag e of 14% of their body weight, exceeding our promise to match clinical trial results of 10% and validating the unique power of our metabolic health program. Our combination of doctor-prescribed, FDA-approved GLP-1 medication and an entirely digital, holistic intensive lifestyle intervention (ILI) drives real results. In our first year, we have proven that Calibrate works. We launched Calibrate with the mission to change the way the world treats weight. Calibrate raises $100 Million Series B one year after launch to tackle obesity at scale
0 kommentar(er)
